Cargando…

P1175: THROMBOTIC RISK IN DLBCL: A REAL-LIFE COMPARISON OF THE THROLY AND MODEL IX SCORES

Detalles Bibliográficos
Autores principales:	Civettini, Ivan, Cavalca, Fabrizio, Zappaterra, Arianna, Crippa, Stefano, Agostani, Elena, Palasciano, Andrea, Antolinni, Laura, Cocito, Federica, Gambacorti-Passerini, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430956/ http://dx.doi.org/10.1097/01.HS9.0000971596.27260.d1

Ejemplares similares

PB2182: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AT DIAGNOSIS IN ESSENTIAL THROMBOCYTEMIA (ET): A NEW PREDICTOR OF THROMBOTIC EVENTS
por: Ripamonti, Alessia, et al.
Publicado: (2023)

PB1976: SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION.
por: Civettini, Ivan, et al.
Publicado: (2023)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization
por: Civettini, Ivan, et al.
Publicado: (2023)

Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study
por: Cavalca, Fabrizio, et al.
Publicado: (2021)

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
por: Rupa‐Matysek, Joanna, et al.
Publicado: (2018)

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Effects of blocking CD24 and CD47 ‘don't eat me’ signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia
por: Aroldi, Andrea, et al.
Publicado: (2023)

SG-APSIC1175: Reusing of single-use devices management
por: Sirijindadirat, Nanthipha
Publicado: (2023)

Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706)
por: Bossi, Elisa, et al.
Publicado: (2022)

1175. Tandem Heart-Associated Fevers: Does the Fever Signify Infection?
por: Hasan, Mustafa, et al.
Publicado: (2019)

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023)

Data Rates Between the ISR Equipment and the Control System (Runs 1174 and 1175)
por: Kemp, D
Publicado: (1981)

Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial
por: Vergnano, Beatrice, et al.
Publicado: (2023)

In vivo mouse spinal cord imaging using echo-planar imaging at 11.75 T
por: Callot, Virginie, et al.
Publicado: (2007)

1175. Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
por: Mitaka, Hayato, et al.
Publicado: (2020)

1175. Influenza Vaccine Hesitancy in Hospitalized Children, Before and During the COVID-19 Pandemic
por: Orbea, Marisa, et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Aroldi, Andrea, et al.
Publicado: (2021)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
por: Fontana, Diletta, et al.
Publicado: (2021)

1175. Clinical and Microbiological Features of Klebsiella pneumoniae Liver Abscess Caused by Multidrug-Resistant Strains
por: Lin, Yi-Tsung, et al.
Publicado: (2018)

SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175
por: Kim, Dong Young, et al.
Publicado: (2019)

Psychiatric comorbid disorders of cognition: a machine learning approach using 1175 UK Biobank participants
por: Li, Chenlu, et al.
Publicado: (2020)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

DLBCL Coast to Coast
por: Tesio, Melania
Publicado: (2018)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells
por: Mologni, Luca, et al.
Publicado: (2012)

Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK
por: Fontana, Diletta, et al.
Publicado: (2015)

Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
por: Inzoli, Elena, et al.
Publicado: (2022)

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
por: Malighetti, Federica, et al.
Publicado: (2023)

Measurement of proton proton elastic scattering in pure initial spin states at 11.75 GeV/c
por: Abe, K, et al.
Publicado: (1976)

VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples
por: Ramazzotti, Daniele, et al.
Publicado: (2021)

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition
por: Mologni, Luca, et al.
Publicado: (2017)

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
por: Hawkes, Eliza A., et al.
Publicado: (2021)

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
por: Vrabac, Damir, et al.
Publicado: (2021)

P1175: REAL LIFE OUTCOMES OF RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTRE EXPERIENCE
por: Dogliotti, I., et al.
Publicado: (2022)

Cardiac Involvement by HIV-Associated DLBCL
por: Mupamombe, Charles T., et al.
Publicado: (2018)

The Tumor Microenvironment of DLBCL in the Computational Era
por: Opinto, Giuseppina, et al.
Publicado: (2020)

Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
por: Renso, Rossella, et al.
Publicado: (2018)

Primary structure of the brain alpha-spectrin [published erratum appears in J Cell Biol 1989 Mar;108(3):following 1175]
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_499ikqe592j0g8pgeeposcishj